These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12492018)

  • 1. Tenofovir DF trial announced by Gilead.
    Eagan L
    Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
    [No Abstract]   [Full Text] [Related]  

  • 2. Promising results for tenofovir.
    AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenofovir (Viread(R)) access for poor countries.
    James JS
    AIDS Treat News; 2002 Dec; (386):6-7. PubMed ID: 12569875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
    Eagan L
    Posit Living; 2001; 10(5):21. PubMed ID: 11693102
    [No Abstract]   [Full Text] [Related]  

  • 5. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
    MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
    [No Abstract]   [Full Text] [Related]  

  • 6. More uses for tenofovir?
    AIDS Treat News; 2001 Jan; (377):4. PubMed ID: 11862808
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
    [No Abstract]   [Full Text] [Related]  

  • 8. Gilead sciences releases Viread.
    Giles C
    Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
    [No Abstract]   [Full Text] [Related]  

  • 9. Tenofovir: FDA hearing on important new antiretroviral.
    James JS
    AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of tenofovir.
    AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892609
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir DF expanded access. Criteria for U.S. program.
    AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cambodia stops important tenofovir prevention trial.
    James JS
    AIDS Treat News; 2004 Jul; (403):4-5. PubMed ID: 15386853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir--long term results from first-line therapy.
    TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
    [No Abstract]   [Full Text] [Related]  

  • 14. Tenofovir drug interactions: ddI and d4T.
    TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
    [No Abstract]   [Full Text] [Related]  

  • 15. Tenofovir approved: broad indication.
    James JS
    AIDS Treat News; 2001 Oct; (373):2-3. PubMed ID: 11768879
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention trials starting.
    AIDS Patient Care STDS; 2004 Jun; 18(6):366-7. PubMed ID: 15384199
    [No Abstract]   [Full Text] [Related]  

  • 17. New uses for tenofovir: more questions about d4T.
    Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
    Richardson D; Lamba H
    Int J STD AIDS; 2004 Mar; 15(3):204-5. PubMed ID: 15038871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential place of tenofovir in antiretroviral treatment regimens.
    Gazzard BG
    Int J Clin Pract; 2001 Dec; 55(10):704-9. PubMed ID: 11777298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.